Molecular Characterization of a Putative Antiretroviral Transcriptional Factor, OTK18

Journal of Immunology

Volumn 172, Issue 1, 2004, Pages 381-391

  Carlson, Kimberly A ^a   Leisman, Gary ^a   Limoges, Jenae ^a   Pohlman, Garrett D ^a   Horiba, Masahide ^a   Buescher, James ^a   Gendelman, Howard E ^a   Ikezu, Tsuneya ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OTK18; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; GENE MUTATION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LONG TERMINAL REPEAT; MACROPHAGE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION; VIRION; ZINC FINGER MOTIF;

EID: 0346103723     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.1.381     Document Type: Article

References (61)

1. Gendelman, H. E., Y. Persidsky, A. Ghorpade, J. Limoges, M. Stins, M. Fiala, and R. Morrisett. 1997. The neuropathogenesis of the AIDS dementia complex. AIDS 11:S35.
2. Zheng, J., and H. E. Gendelman. 1997. The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr. Opin. Neurol. 10:319.
3. Gendelman, H. E., J. Zheng, C. L. Coulter, A. Ghorpade, M. Che, M., Thylin, R. Rubocki, Y. Persidsky, F. Hahn, J. Reinhard, Jr., and S. Swindells. 1998. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J. Infect. Dis. 178:1000.
4. Anderson, E., W. Zink, H. Xiong, and H. E. Gendelman. 2002. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J. Acquired Immune Defic. Syndr. 31(Suppl. 2):S43.
5. Aiken, C., and D. Trono. 1995. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:5048.
6. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N., Sharoya, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666.
7. Chowdhury, I. H., W. Chao, M. J. Potash, P. Sova, H. E. Gendelman, and D. J. Volsky. 1996. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. J. Virol. 70:5336.
8. Conti, L., P. Matarrese, B. Varano, M. C. Gauzzi, A. Sato, W. Malomi, F. Belardelli, and S. Gessani. 2000. Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells. J. Immunol. 165:3293.
9. Poon, B., K. Grovit-Ferbas, S. A. Stewart, and I. S. Chen. 1998. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science 281:266.
10. Taube, R., K. Fujinaga, J. Wimmer, M. Barboric, and B. M. Peterlin. 1999. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology 264:245.
11. Gait, M. J., and J. Karn. 1993. RNA recognition by the human immunodeficiency virus Tat and Rev proteins. Trends Biochem. Sci. 18:255.
12. Cicala, C., J. Arthos, S. M. Selig, G. Dennis, Jr., D. A. Hosack, D. Van Ryk, M. L. Spangler, T. D. Steenbeke, P. Khazanie, N. Gupta, et al. 2002. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc. Natl. Acad. Sci. USA 99:9380.
13. Patarca, R., G. J. Freeman, J. Schwartz, R. P. Singh, Q. T. Kong, E. Murphy, Y. Anderson, F. Y. Sheng, P. Singh, K. A. Johnson, et al. 1988. rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 85:2733.
14. Ray, R. B., and R. V. Srinivas. 1997. Inhibition of human immunodeficiency virus type 1 replication by a cellular transcriptional factor MBP-1. J. Cell Biochem 64:565.
15. Subler, M. A., D. W. Martin, and S. Deb. 1994. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53. J. Virol. 68:103.
16. Herchenroder, O., J. C. Hahne, W. K. Meyer, H. J. Thiesen, and J. Schneider. 1999. Repression of the human immunodeficiency virus type 1 promoter by the human KRAB domain results in inhibition of virus production. Biochim. Biophys. Acta 1445:216.
17. Zink, W., L. Ryan, and H. E. Gendelman. 2002. Macrophage-virus interactions. In The Macrophage. B. Burke and C. Lewis, eds. Oxford University Press, New York, p. 305.
18. Gabuzda, D., J. Hess, J. Small, and J. Clements. 1989. Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites. Mol. Cell. Biol. 9:2973.
19. Glass, J. D., H. Fedor, S. L. Wesselingh, and J. C. McArthur. 1995. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlation with dementia. Ann. Neurol. 38:755.
20. Canonne-Hergaux, F., D. Aunis, and E. Schaeffer. 1995. Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells. J. Virol. 69:6634.
21. Sawaya, B. E., O. Rohr, D. Aunis, and E. Schaeffer. 1996. Chicken ovalbumin upstream promoter transcription factor, a transcriptional activator of HIV-1 gene expression in human brain cells. J. Biol. Chem. 271:23572.
22. Rohr, O., D. Aunis, and E. Schaeffer. 1997. COUP-TF and Sp1 interact and cooperate in the transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat in human microglial cells. J. Biol. Chem. 272:31149.
23. Rohr, O., C. Schwartz, C. Hery, D. Aunis, M. Tardieu, and E. Schaeffer. 2000. The nuclear receptor chicken ovalbumin upstream promoter transcription factor interacts with HIV-1 Tat and stimulates viral replication in human microglial cells. J. Biol. Chem. 275:2654.
24. Saito, H., T. Fujiwara, E. I. Takahashi, S. Shin, K. Okui, and Y. Nakamura. 1996. Isolation and mapping of a novel human gene encoding a protein containing zinc-finger structures. Genomics 31:376.
25. Bellefroid, E. J., D. A. Poncelet, P. J. Lecocq, O. Revelant, and J. A. Martial. 1991. The evolutionarily conserved Kruppel-associated box domain defines a subfamily of eukaryotic multifingered proteins. Proc. Natl. Acad. Sci. USA 88:3608.
26. Gendelman, H. E., J. M. Orenstein, M. A. Martin, C. Ferrua, R. Mitra, T. Phipps, L. A. Wahl, H. C. Lane, A. S. Fauci, D. S. Burke, et al. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167:1428.
27. Kalter, D. C., M. Nakamura, J. A. Turpin, L. M. Baca, D. L. Hoover, C. Dieffenbach, P. Ralph, H. E. Gendelman, and M. S. Meltzer. 1991. Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. J. Immunol. 146:298.
28. Ikezu, T., X. Luo, G. A. Weber, J. Zhao, L. McCabe, J. L. Buescher, A. Ghorpade, J. Zheng, and H. Xiong. 2003. Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Aβ-mediated neurotoxicity. J. Neurochem. 85:925.
29. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509.
30. Cotter, R. L., J. Zheng, M. Che, D. Niemann, Y. Liu, J. He, E. Thomas, and H. E. Gendelman. 2001. Regulation of human immunodeficiency virus type 1 infection, β-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry. J. Virol. 75:4308.
31. Subramani, S., R. Mulligan, and P. Berg. 1981. Expression of the mouse dihydrofolate reductase complementary deoxyribonucleic acid in simian virus 40 vectors. Mol. Cell. Biol. 1:854.
32. Zeichner, S. L., J. Y. Kim, and J. C. Alwine. 1991. Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 65:2436.
33. Johnson, D. 1995. Murine monoclonal antibody development. In Methods in Molecular Biology, Vol. 51. S. Paul, ed. Humana Press, Totowa, p. 123.
34. Liang, P., and A. B. Pardee. 1992. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967.
35. Lowe, W. L., Jr., R. Fu, and M. Banko. 1997. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3′,5′-mono-phosphate in MCF-7 breast cancer cells. Endocrinology 138:2219.
36. Rosati, M., M. Marino, A. Franze, A. Tramontano, and G. Grimaldi. 1991. Members of the zinc finger protein gene family sharing a conserved N-terminal module. Nucleic Acids Res. 19:5661.
37. Kaufmann, A., R. Salentin, D. Gemsa, and H. Sprenger. 2001. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1α during differentiation of human monocytes to macrophages. J. Leukocyte Biol. 69:248.
38. Gendelman, H. E., and P. M. Morahan. 1992. The macrophage in viral infections. In The Natural Immune System Series: The Macrophage. C. E. Lewis and J. McGee, eds. Oxford University Press, London, p. 156.
39. Gendelman, H. E., D. R. Skillman, and M. S. Meltzer. 1992. Interferon α (IFN)-macrophage interactions in human immunodeficiency virus (HIV) infection: role of IFN in the tempo and progression of HIV disease. Int. Rev. Immunol. 8:43.
40. Baca, L. M., P. Genis, D. Kalvakolanu, G. Sen, M. S. Meltzer, A. Zhou, R. Silverman, and H. E. Gendelman. 1994. Regulation of interferon-α -inducible cellular genes in human immunodeficiency virus-infected monocytes. J. Leukocyte Biol. 55:299.
41. Gendelman, H. E., T. Baldwin, L. Baca-Regen, S. Swindells, L. Loomis, and S. Skurkovich. 1994. Regulation of HIV1 replication by interferon α: from laboratory bench to bedside. Res. Immunol. 145:679.
42. Kornbluth, R. S., K. Kee, and D. D. Richman. 1998. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines. Proc. Natl. Acad. Sci. USA 95:5205.
43. Kitai, R., M. Zhao, N. Zhang, L. L. Hua, and S. C. Lee. 2000. Role of MIP-1β and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNβ. J. Neuroimmunol. 110:230.
44. Kornbluth, R. S., P. S. Oh, J. R. Munis, P. H. Cleveland, and D. D. Richman. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169:1137.
45. Bernstein, M. S., S. E. Tong-Starksen, and R. M. Locksley. 1991. Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression. J. Clin. Invest. 88:540.
46. von Briesen, H., C. von Mallinckrodt, R. Esser, S. Muller, K. Becker, H. Rubsamen-Waigmann, and R. Andreesen. 1991. Effect of cytokines and lipopolysaccharides on HIV infection of human macrophages. Res. Virol. 142:197.
47. Zybarth, G., N. Reiling, H. Schmidtmayerova, B. Sherry, and M. Bukrinsky. 1999. Activation-induced resistance of human macrophages to HIV-1 infection in vitro. J. Immunol. 162:400.
48. Franchin, G., G. Zybarth, W. W. Dai, L. Dubrovsky, N. Reiling, H. Schmidtmayerova, M. Bukrinsky, and B. Sherry. 2000. Lipopolysaccharide inhibits HIV-1 infection of monocyte-derived macrophages through direct and sustained down-regulation of CC chemokine receptor 5. J. Immunol. 164:2592.
49. Suzan, M., D. Salaun, C. Neuveut, B. Spire, I. Hirsch, P. Le Bouteiller, G. Querat, and J. Sire. 1991. Induction of NF-κB during monocyte differentiation by HIV type 1 infection. J. Immunol. 146:377.
50. Akira, S., and T. Kishimoto. 1992. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol. Rev. 127:25.
51. Tesmer, V. M., A. Rajadhyaksha, J. Babin, and M. Bina. 1993. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:7298.
52. Henderson, A. J., X. Zou, and K. L. Calame. 1995. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J. Virol. 69:5337.
53. Griffin, G. E., K. Leung, T. M. Folks, S. Kunkel, and G. J. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-κB. Nature 339:70.
54. Henderson, A. J., R. I. Connor, and K. L. Calame. 1996. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5:91.
55. Mann, D. L., S. Gartner, F. LeSane, W. A. Blattner, and M. Popovic. 1990. Cell surface antigens and function of monocytes and a monocyte-like cell line before and after infection with HIV. Clin. Immunol. Immunopathol. 54:174.
56. Evans, R. M., and S. M. Hollenberg. 1988. Zinc fingers: gilt by association. Cell 52:1.
57. Shannon, M., L. K. Ashworth, M. L. Mucenski, J. E. Lamerdin, E. Branscomb, and L. Stubbs. 1996. Comparative analysis of a conserved zinc finger gene cluster on human chromosome 19q and mouse chromosome 7. Genomics 33:112.
58. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529.
59. Pengue, G., A. Caputo, C. Rossi, G. Barbanti-Brodano, and L. Lania. 1995. Transcriptional silencing of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by the Kruppel-associated box repressor domain targeted to the transactivating response element. J. Virol. 69:6577.
60. Reynolds, L., C. Ullman, M. Moore, M. Isalan, M. J. West, P. Clapham, A. Klug, and Y. Choo. 2003. Repression of the HIV-1 5′ LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors. Proc. Natl. Acad. Sci. USA 100:1615.
61. Gao, G., X. Guo, and S. P. Goff. 2002. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297:1703.